Nanogen and The Elitech Group to Merge
Nanogen, a molecular and point-of-care diagnostics company, will merge with The Elitech Group, a private French diagnostics company. Elitech has been on a tear of […]
news2
Inovio Biomedical Extends Agreement with the Internation AIDS Vaccine Initiative
Seth Berkley, head of the IAVI or International AIDS Vaccine Initiative (a not-for-profit developing preventive HIV vaccines) believes the majority of HIV vaccines now under […]
Thermage Q2: Robust Results in Ailing Aesthetics Market
Despite the slowdown seen in the aesthetics market, second quarter revenue at Thermage totaled $17.9 million, a 2% increase over Q2 2007. International revenue increased […]
Healthcare Reform 2008: Evolution or Revolution?
Healthcare reform is high on the political agenda this year. The upcoming Presidential and Congressional elections promise to focus public and business leaders’ attention on […]
Signalife Throws in the Towel
After battling for over a year to retain its AMEX listing, Signalife has thrown in the towel. The company will voluntarily withdraw its common stock […]
Arbios Systems Runs Out of Steam
Arbios Systems has suspended operations and laid-off employees while it focuses on raising additional funds. If the company fails to secure financing by the end […]
Chembio Q2 Results: Record Revenues, Net Loss Decreases
Chembio Diagnostics reported second quarter revenues of $2.72 million, an 8.6% increase over Q2 2007 and higher than any previous quarter. The lion’s share of […]
[Video] On Greatbatch, Stereotaxis: Interview with Keay Nakae, Analyst at Collins Stewart
In this video, Keay discusses Greatbatch, which he believes is a compelling buy based on its current valuation. Keay also discusses Stereotaxis. The company has […]
Electro-Optical Sciences Nears Pivotal Trial Completion
Electro-Optical Sciences (EOS), developer of The MelaFind System, a hand held imaging device that detects melanomas at an early stage, has completed patient accrual in […]
Langer Cuts the Fat: Sells Bi-Op Subsidiary for Less than 2003 Purchase Price
Langer, Inc. has completed the sale of Bi-Op Laboratories for $2,125,000 in cash. Buyers include a group of investors and Raynald Henry, the current Bi-Op […]